Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Circulation ; 125(4): 604-14, 2012 Jan 31.
Artigo em Inglês | MEDLINE | ID: mdl-22203696

RESUMO

BACKGROUND: The present study was aimed at determining the impact of type 2 diabetes mellitus (DM) on postoperative bioprosthetic structural valve degeneration. METHODS AND RESULTS: Twelve Italian centers participated in the study. Patient data refer to bioprosthetic implantations performed from November 1988 to December 2009, which resulted in 6184 patients (mean age 71.3±5.4 years, 60.1% male) being enrolled. Of these patients, 1731 (27.9%) had type 2 DM. The propensity score-matching algorithm successfully matched 1113 patients with type 2 DM with the same number of no-DM patients. The postmatching standard differences were less than 0.1 for each of the covariates, and 64.2% of DM patients were matched. The early (30 days) mortality rate was 7.8% (n=87) versus 2.9% (n=33) in patients with or without type 2 DM (P<0.001), respectively. Seven-year freedom from valve deterioration was significantly lower in patients with DM (73.2% [95% confidence interval, 61.6-85.5] versus 95.4% [95% confidence interval, 83.9-100], P<0.001). In Cox regression models with robust SEs that accounted for the clustering of matched pairs, DM was the strongest predictor of structural valve degeneration (hazard ratio 2.39 [95% confidence interval 2.28-3.52]). When we allowed for interaction between type 2 DM and other key risk factors, DM remained a significant predictor beyond any potentially associated variable. CONCLUSIONS: Patients with type 2 DM undergoing bioprosthetic valve implantation are at high risk of early and long-term mortality, as well as of structural valve degeneration.


Assuntos
Bioprótese/estatística & dados numéricos , Diabetes Mellitus Tipo 2/mortalidade , Doenças das Valvas Cardíacas/mortalidade , Próteses Valvulares Cardíacas/estatística & dados numéricos , Complicações Pós-Operatórias/mortalidade , Falha de Prótese/efeitos adversos , Idoso , Feminino , Seguimentos , Hemoglobinas Glicadas/metabolismo , Doenças das Valvas Cardíacas/cirurgia , Humanos , Hiperglicemia/mortalidade , Incidência , Unidades de Terapia Intensiva/estatística & dados numéricos , Itália/epidemiologia , Masculino , Análise Multivariada , Valor Preditivo dos Testes , Fatores de Risco
2.
Artigo em Inglês | MEDLINE | ID: mdl-22256302

RESUMO

A tissue bath system, to be used as an alternative to complex perfusion chambers, was constructed for use in cardiac electrophysiological studies. This system consists of an acrylic chamber to hold circulating physiological medium such as DMEM, suspended in a water bath warmed by a hot plate. Temperature and pH were controlled to mimic physiological conditions. Rat and porcine cardiac tissues, were used to test viability of the conditions presented in the bath system. Using a cardiac mapping system, the tissues were stimulated and responses recorded. From the recordings we were able to calculate conduction velocities and spatial dispersion of activation indices. The results are comparable to previous in-vivo work, which suggests that the tissue bath system design can maintain tissue viability. This tissue bath system is a relatively simple alternative for ex-vivo testing of cardiac tissues.


Assuntos
Fenômenos Eletrofisiológicos , Coração/fisiologia , Técnicas de Cultura de Tecidos/economia , Técnicas de Cultura de Tecidos/instrumentação , Animais , Condutividade Elétrica , Masculino , Ratos , Ratos Sprague-Dawley , Sus scrofa , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa